- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07293143
Glycemic Effects of Meals - Repeatability Trial With Continuous Glucose Monitoring (GEM-RT CGM)
Almost half of adults in the United States have either diabetes mellitus (DM) or prediabetes (preDM), but many are undiagnosed and unaware of their condition. Current DM diagnosis and risk prediction are based on single "snapshot" measurements including: fasting blood glucose, postprandial glucose, and hemoglobin (Hb)A1c. Continuous glucose monitoring (CGM) offers a dynamic view of glucose levels throughout the day which enables characterizing individuals' dynamic glycemic profiles in response to physiological and environmental stimuli better than the conventional point-in-time glucose quantification approaches. By analyzing glycemic patterns from CGM tracings, it may be possible to identify individuals at increased risk of developing diabetes. However, an important prerequisite is to establish the reliability and consistency of glucose response patterns captured by CGM under controlled conditions.
Participants will be given six different meals to examine the glucose responses to these meals. Two of these meals (white rice and an Ensure drink) will be given twice for each participant to investigate whether individuals have the same glucose response to the same meal given on different days. Glucose will be measured using continuous glucose monitors, that have a thin wire sensor that measures glucose under the skin every five minutes for up to 10 days.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a pilot study in which each participant undergoes six meal challenges (one each morning) under free-living conditions, while wearing a blinded CGM sensor. Glucose levels will be continuously measured, and meal challenge sequence will be randomly assigned to each participant.
The study objectives are to:
- determine the within meal replicability of postprandial glucose response to a Ensure and White Rice meal challenges
- evaluate if a whole food meal challenge (White Rice) exhibits lower reliability and greater physiological variability (under the chewing vs. not chewing condition) in postprandial glucose response compared to a standardized liquid mixed meal tolerance test (Ensure)
- compare the postprandial average peak glucose response and 4 hour incremental area under the curve (iAUC) for the Ensure tolerance test, mountain dew tolerance test, White Rice, and typical breakfast.
These findings will inform the design of future studies and the potential use of CGM-based dietary challenges for early detection of metabolic risk.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nicole L Spartano, PhD
- Phone Number: 315-415-2040
- Email: spartano@bu.edu
Study Contact Backup
- Name: Bahar Bakshi, MS
- Phone Number: (315) 415-2040
- Email: baharb@bu.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Generally healthy
- English speaking
Exclusion Criteria:
- Prior diagnosis of diabetes or taking medications that influence glucose metabolism, such as insulin, glucocorticoids, or Glucagon-like peptide-1 (GLP-1) receptor agonists.
- Taking hydroxyurea medication
- Taking beyond the maximum dose of acetaminophen (4g/day)
- Known food allergies or severe sensitivities to any study materials (dairy or soy)
- Limited and non-readers
- Cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Continuous glucose monitoring
Each participant will have a Dexcom G6 CGM sensor applied to the upper arm.
The order of the six study meals will be randomly assigned.
|
Two of the meal challenges will only be provided once: (1) a 20oz bottle of Mountain Dew (2) a "typical breakfast" that participants would eat normally.
The other four challenges consist of two meal events that will each be repeated: (1) two 8-ounce bottles of Ensure® nutritional shake (2) one cup of microwaved white rice (microwaveable Minute brand Jasmine Rice cups).
The rice challenge will be performed once with normal chewing and once by swallowing without chewing, while the Ensure challenge will be repeated the same way on both days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycemic patterns from CGM
Time Frame: baseline, every 4 hours for 6 days
|
Beginning at baseline, a 4-hour incremental area under the glucose curve (iAUC) will be calculated using the trapezoidal method.
Peak glucose will be defined as the maximum glucose excursion within the 4-hour window.
Continuous glucose monitoring (CGM) CGM values are recorded every 5 minutes, so linear interpolation will be used to provide a CGM value every minute to line up with the ingestion time documented in the participant's log.
|
baseline, every 4 hours for 6 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fasting blood glucose levels
Time Frame: baseline, daily for 6 days
|
This outcome will be assessed from the CGM data recorded after a10 hour fast.
|
baseline, daily for 6 days
|
|
Post prandial glucose levels
Time Frame: baseline, daily for 6 days
|
This outcome will be assessed from the CGM data recorded daily 4 hours after a study meal.
|
baseline, daily for 6 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nicole L Spartano, PhD, BUCA School of Medicine, Endocrinology, Diabetes, Nutrition and Weight Management
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- H-46249
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Response
-
Clinical Nutrition Research Centre, SingaporeUniversity of GuelphCompleted
-
University of UdineWageningen University and ResearchCompletedGlycemic Index | Oral Processing | Glucose Response | Insulin ResponseItaly
-
Purdue UniversityNot yet recruitingPostprandial Metabolism | Insulin Response | Postprandial Glucose Response | Lactose Digestion
-
Aventure ABCompletedBlood Glucose ResponseSweden
-
NestléCompletedPostprandial Glucose ResponseSwitzerland
-
Quadram Institute BioscienceNorfolk and Norwich University Hospitals NHS Foundation TrustCompleted
-
University Malaysia SarawakCompleted
-
Mondelēz International, Inc.Glycemic Index Laboratories, IncCompleted
-
KU LeuvenCompletedGastric Emptying | Energy Intake | Satiety | Appetite | Glucose Response | Insulin ResponseBelgium
-
West German Center of Diabetes and HealthBionorica SECompletedPostprandial Glucose Response | Glycaemic Index | Continous Glucose MeasurementGermany
Clinical Trials on Six meal challenges
-
Bezmialem Vakif UniversityCompletedOverweight and ObesityTurkey
-
Oregon Health and Science UniversityNot yet recruiting
-
McGill UniversityRecruiting
-
Cambridge University Hospitals NHS Foundation TrustImperial College London; University of ManchesterUnknown
-
University Hospital, GenevaFood Allergy Research & Education; Allergistiftung Ulrich MüllerCompletedNut Allergy in ChildrenUnited Kingdom, Switzerland, Spain
-
Herning HospitalKolding SygehusCompleted
-
Bhumibol Adulyadej HospitalNot yet recruitingFluid Responsiveness
-
Kansas State UniversityFrontiers Clinical & Translational Science InstituteCompletedDepression and Anxiety SymptomUnited States
-
Universidade Federal de PernambucoCompletedObstructive Sleep ApneaBrazil